Healthcare provider profile · identity verified

Gordon David Long, M.D.

Family Practice · ONTARIO, OH · NPI 1487769766

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	664	207
Levothyroxine Sodium	Levothyroxine Sodium	302	84
Metformin Hcl	Metformin Hcl	240	84
Amlodipine Besylate	Amlodipine Besylate	218	76
Lisinopril	Lisinopril	197	71
Metoprolol Succinate	Metoprolol Succinate	189	70
Bupropion Xl	Bupropion Hcl	185	54
Meloxicam	Meloxicam	175	64
Omeprazole	Omeprazole	173	59
Duloxetine Hcl	Duloxetine Hcl	169	55
Rosuvastatin Calcium	Rosuvastatin Calcium	165	52
Escitalopram Oxalate	Escitalopram Oxalate	159	53
Pantoprazole Sodium	Pantoprazole Sodium	142	50
Losartan Potassium	Losartan Potassium	136	48
Gabapentin	Gabapentin	135	39
Celecoxib	Celecoxib	134	43
Glimepiride	Glimepiride	126	40
Tamsulosin Hcl	Tamsulosin Hcl	123	41
Allopurinol	Allopurinol	120	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	116	35
Pravastatin Sodium	Pravastatin Sodium	111	32
Trazodone Hcl	Trazodone Hcl	111	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	32
Metformin Hcl Er	Metformin Hcl	103	36
Pregabalin	Pregabalin	103	32
Ezetimibe	Ezetimibe	100	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	97	33
Hydrochlorothiazide	Hydrochlorothiazide	90	31
Sertraline Hcl	Sertraline Hcl	89	26
Ozempic	Semaglutide	88	17
Esomeprazole Magnesium	Esomeprazole Magnesium	81	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	25
Famotidine	Famotidine	79	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	76	28
Clopidogrel	Clopidogrel Bisulfate	72	27
Eliquis	Apixaban	71	20
Valsartan	Valsartan	71	28
Alprazolam	Alprazolam	70	21
Clonazepam	Clonazepam	67	21
Alendronate Sodium	Alendronate Sodium	66	17
Diclofenac Sodium	Diclofenac Sodium	66	26
Metoprolol Tartrate	Metoprolol Tartrate	63	18
Aripiprazole	Aripiprazole	62	22
Furosemide	Furosemide	61	28
Zolpidem Tartrate	Zolpidem Tartrate	61	30
Mirtazapine	Mirtazapine	56	18
Citalopram Hbr	Citalopram Hydrobromide	54	20
Paroxetine Hcl	Paroxetine Hcl	54	17
Donepezil Hcl	Donepezil Hcl	52	19
Ropinirole Hcl	Ropinirole Hcl	51	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	50	19
Tizanidine Hcl	Tizanidine Hcl	50	14
Carvedilol	Carvedilol	48	17
Atenolol	Atenolol	47	18
Albuterol Sulfate Hfa	Albuterol Sulfate	46	24
Hydroxyzine Hcl	Hydroxyzine Hcl	46	12
Jardiance	Empagliflozin	46	15
Montelukast Sodium	Montelukast Sodium	46	17
Lansoprazole	Lansoprazole	45	21
Trulicity	Dulaglutide	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Tresiba Flextouch U-100	Insulin Degludec	42	suppressed
Tramadol Hcl	Tramadol Hcl	40	13
Simvastatin	Simvastatin	39	14
Fluticasone Propionate	Fluticasone Propionate	38	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	13
Propranolol Hcl Er	Propranolol Hcl	36	12
Quetiapine Fumarate	Quetiapine Fumarate	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	14
Finasteride	Finasteride	35	11
Rexulti	Brexpiprazole	35	11
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Nadolol	Nadolol	33	suppressed
Farxiga	Dapagliflozin Propanediol	32	11
Olmesartan Medoxomil	Olmesartan Medoxomil	32	13
Synthroid	Levothyroxine Sodium	31	12
Testosterone Cypionate	Testosterone Cypionate	31	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	30	11
Memantine Hcl	Memantine Hcl	29	suppressed
Spironolactone	Spironolactone	29	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Potassium Chloride	Potassium Chloride	27	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Colesevelam Hcl	Colesevelam Hcl	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Linzess	Linaclotide	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Dutasteride	Dutasteride	21	suppressed
Topiramate	Topiramate	21	suppressed
Estradiol	Estradiol	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Belsomra	Suvorexant	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Kerendia	Finerenone	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glipizide	Glipizide	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Prolia	Denosumab	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	13
Nifedipine Er	Nifedipine	15	suppressed
Paliperidone Er	Paliperidone	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Humalog Kwikpen U-200	Insulin Lispro	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Baclofen	Baclofen	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Gemtesa	Vibegron	12	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Temazepam	Temazepam	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Prednisone	Prednisone	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error